Redundant and Alternative Roles for Activating Fc Receptors and Complement in an Antibody-Dependent Model of Autoimmune Vitiligo

Baumann, 2000, A codominant role of Fc gamma RI/III and C5aR in the reverse Arthus reaction, J. Immunol., 164, 1065, 10.4049/jimmunol.164.2.1065 Bowne, 1999, Coupling and uncoupling of tumor immunity and autoimmunity, J. Exp. Med., 190, 1717, 10.1084/jem.190.11.1717 Clynes, 1995, Cytotoxic antibodies trigger inflammation through Fc receptors, Immunity, 3, 21, 10.1016/1074-7613(95)90155-8 Clynes, 1998, Fc receptors are required in passive and active immunity to melanoma, Proc. Natl. Acad. Sci. USA, 95, 652, 10.1073/pnas.95.2.652 Clynes, 2000, Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets, Nat. Med., 6, 443, 10.1038/74704 Fischer, 1996, Regulation of the B cell response to T-dependent antigens by classical pathway complement, J. Immunol., 157, 549, 10.4049/jimmunol.157.2.549 Hahne, 1996, Melanoma cell expression of Fas(Apo-1/CD95) ligand, Science, 274, 1363, 10.1126/science.274.5291.1363 Hara, 1995, Implicating a role for immune recognition of self in tumor rejection, J. Exp. Med., 182, 1609, 10.1084/jem.182.5.1609 Hazenbos, 1996, Impaired IgG-dependent anaphylaxis and Arthus reaction in Fcγ RIII (CD16) deficient mice, Immunity, 5, 181, 10.1016/S1074-7613(00)80494-X Heller, 1999, Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury, J. Immunol., 163, 985, 10.4049/jimmunol.163.2.985 Hernandez-Caselles, 1993, Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation, J. Immunol., 151, 3999, 10.4049/jimmunol.151.8.3999 Hopken, 1997, Impaired inflammatory responses in the reverse Arthus reaction through genetic deletion of the C5a receptor, J. Exp. Med., 186, 749, 10.1084/jem.186.5.749 Itohara, 1993, T cell receptor Δ gene mutant mice, Cell, 72, 337, 10.1016/0092-8674(93)90112-4 Kitamura, 1991, A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene, Nature, 350, 423, 10.1038/350423a0 Kock, 1990, Human keratinocytes are a source for tumor necrosis factor alpha, J. Exp. Med., 172, 1609, 10.1084/jem.172.6.1609 Kohl, 1999, On the role of complement and Fc gamma-receptors in the Arthus reaction, Mol. Immunol., 36, 893, 10.1016/S0161-5890(99)00111-X Kunisada, 1998, Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor, J. Exp. Med., 187, 1565, 10.1084/jem.187.10.1565 Leder, 1964, The selective enzymocytochemical demonstration of neutrophil myeloid cells and tissue mast cells in paraffin sections, Klin. Wochenschr., 42, 553, 10.1007/BF01486688 Molina, 1996, Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2, Proc. Natl. Acad. Sci. USA, 93, 3357, 10.1073/pnas.93.8.3357 Mombaerts, 1992, RAG-1-deficient mice have no mature B and T lymphocytes, Cell, 68, 869, 10.1016/0092-8674(92)90030-G Naftzger, 1996, Immune response to a differentiation antigen induced by altered antigen, Proc. Natl. Acad. Sci. USA, 93, 14809, 10.1073/pnas.93.25.14809 Nakamura, 2000, Fcγ receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen, J. Exp. Med., 191, 899, 10.1084/jem.191.5.899 Nakayama, 1994, Targeted disruption of Bcl-2 alpha beta in mice, Proc. Natl. Acad. Sci. USA, 91, 3700, 10.1073/pnas.91.9.3700 Nordlund, 1998, Vitiligo vulgaris Odling, 1987, Effects of low or high doses of short wavelength ultraviolet light (UVB) on Langerhans cells and skin allograft survival, Immunol. Cell Biol., 65, 337, 10.1038/icb.1987.38 Overwijk, 1999, Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice, Proc. Natl. Acad. Sci. USA, 96, 2982, 10.1073/pnas.96.6.2982 Rahemtulla, 1991, Mice lacking CD4 have normal development and function of CD8+ cells but have markedly decreased helper cell activity, Nature, 353, 180, 10.1038/353180a0 Ravetch, 1998, Divergent roles for Fc receptors and complement in vivo, Annu. Rev. Immunol., 16, 421, 10.1146/annurev.immunol.16.1.421 Song, 1994, The role of tyrosinase in autoimmune vitiligo, Lancet, 344, 1049, 10.1016/S0140-6736(94)91709-4 Sylvestre, 1996, Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice, J. Exp. Med., 184, 2385, 10.1084/jem.184.6.2385 Takai, 1994, FcR γ chain deletion results in pleiotrophic effector cell defects, Cell, 76, 519, 10.1016/0092-8674(94)90115-5 Takai, 1996, Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice, Nature, 379, 346, 10.1038/379346a0 Takechi, 1996, A melanosomal membrane protein is a cell surface target for melanoma therapy, Clin. Cancer Res., 2, 1837 Thomson, 1988, Differentiation antigens of melanocytes and melanoma, J. Invest. Dermatol., 90, 459, 10.1111/1523-1747.ep12460906 Tigelaar, 1995, Immunobiology of mouse dendritic epidermal T cells, J. Invest. Dermatol., 105, 43, 10.1038/jid.1995.9 Vijayasaradhi, 1990, The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product, J. Exp. Med., 171, 1375, 10.1084/jem.171.4.1375 Vijayasaradhi, 1995, Intracellular sorting and targeting of melanosomal membrane proteins, J. Cell Biol., 130, 807, 10.1083/jcb.130.4.807 Weber, 1998, Tumor immunity and autoimmunity induced by immunization with homologous DNA, J. Clin. Invest., 102, 1258, 10.1172/JCI4004 Wessels, 1995, Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity, Proc. Natl. Acad. Sci. USA, 92, 11490, 10.1073/pnas.92.25.11490 Yuasa, 1999, Deletion of fcγ receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis, J. Exp. Med., 189, 187, 10.1084/jem.189.1.187